International Journal of Drug Delivery Technology
Volume 14, Issue 2

Liposomes in Medicine: An In-depth Analysis of Preparation Methods and Applications

Diptee Gupta*, Suruchi Agarwal, Kavitha Komire, Vishal Kumar

Department of Pharmaceutics, Krishna Institute of Pharmacy and Sciences, Kanpur, Uttar Pradesh, India. 

Received: 11th January, 2024; Revised: 11th March, 2024; Accepted: 25th May, 2024; Available Online: 25th June, 2024 

ABSTRACT

Liposomes are the targeted drug administration system that offers the potential to improve the medicinal value of drugs by boosting the concentration of medication the duration of time in intended cells, thereby reducing side effects. Liposomes, which are sphere-shaped vesicles built from phospholipids and cholesterol, are being investigated extensively as a means of increasing the bioavailability and delivery of therapeutic medications. Liposomes have both hydrophilic head and hydrophobic tail and exhibit eminent properties, including reduced toxicity, better biocompatibility, easily biodegradable, easy to function and enhanced sustained release of drugs with increased therapeutic efficacy. Liposomes are said to be an ideal drug-carrier system as they enhance the delivery of anticancer drugs at the tumor site. Since liposomes are amphiphilic carriers that may be modified to have various functional characteristics, they are seen as a potential technology for a range of pharmacological and industrial uses. As a potential way to carry drug delivery across cell membranes, liposomes help medications to target specific disease sites. Liposomes are employed to deliver genetic material, such as DNA fragments, to specified cells so they may synthesize certain proteins. Thus, liposomes are investigated as adaptable nano-vesicular vehicles with potential medical applications for medicinal and diagnostic purposes. The future of liposomal formulations is projected to be a multipurpose use of imaging capabilities and medicinal components in a single liposome for diagnostic and actual-time therapy. The most promising approach for topical administration is liposomal drug delivery since it is compatible with living systems and can accommodate simultaneously hydrophobic and hydrophilic medicated substances because of the amphipathic feature of phospholipids.

Keywords: Liposomes, Amphiphilic, Hydrophobic, Cancer therapy, Applications, Targeting technique. International Journal of Drug Delivery Technology (2024); DOI: 10.25258/ijddt.14.2.81

How to cite this article: Gupta D, Agarwal S, Komire K, Kumar V. Liposomes in Medicine: An In-depth Analysis of Preparation Methods and Applications. International Journal of Drug Delivery Technology. 2024;14(2):1148-1161.

REFERENCES

  1. Daraee H, Etemadi A, Kouhi M, Alimirzalu S, Akbarzadeh A. Application of liposomes in medicine and drug delivery. Artif Cells Nanomed Biotechnol. 2016 Jan 2;44(1):381-91.
  2. Pandya BD, Diwakar SA, Saluja AK. A review on advances of liposomes as drug delivery. European j. pharm. med. res. 2022 Oct 24;9(11):294–307.
  3. Maja L, Željko K, Mateja Sustainable technologies for liposome preparation. J Supercrit Fluids. 2020 Nov 1;165:104984.
  4. Large DE, Abdelmessih RG, Fink EA, Auguste DT. Liposome composition in drug delivery design, synthesis, characterization, and clinical application. Adv. Drug Deliv. Rev. 2021 Sep 1;176:113851.
  5. Barenholz Y. Liposome application: problems and prospects. Curr. opin. colloid interface sci. 2001 Feb 1;6(1):66-77.
  6. Liu G, Hou S, Tong P, Li Liposomes: Preparation, Characteristics, and Application Strategies in Analytical Chemistry. Crit Rev Anal Chem. 2022 Feb 17;52(2):392–412
  7. Mishra H, Chauhan V, Kumar K, Teotia D. A comprehensive review on Liposomes: a novel drug delivery J. drug deliv. ther. 2018 Nov 25;8(6):400-4.
  8. Nel J, Elkhoury K, Velot É, Bianchi A, Acherar S, Francius G, et al. Functionalized liposomes for targeted breast cancer drug delivery. Bioact. Mater. 2023 Jun; 24:401–37.
  9. Shah S, Dhawan V, Holm R, Nagarsenker MS, Perrie Y. Liposomes: Advancements and innovation in the manufacturing process. Adv. Drug Deliv. Rev. 2020;154–155:102–22.
  10. Paul S, Paul AB, Majumdar S, Roy T, Chandra S, Chowdhury VR. Formulation and evaluation of ciprofloxacin hydrochloride encapsulated liposomal hydrogel for dermal administration. IJPSR. 2021;12(6):3249–56.
  11. Liu P, Chen G, Zhang J. A Review of Liposomes as a Drug Delivery System: Current Status of Approved Products, Regulatory Environments, and Future Perspectives. Molecules. 2022 Feb 17;27(4):1372.
  12. Nsairat H, Khater D, Sayed U, Odeh F, Al Bawab A, Alshaer Liposomes: structure, composition, types, and clinical applications. Heliyon. 2022 May;8(5):e09394.
  13. Andra VV, Pammi SV, Bhatraju LV, Ruddaraju A comprehensive review on novel liposomal methodologies, commercial formulations, clinical t rials and patents. BioNanoScience. 2022 Mar;12(1):274-91.
  14. Maheswaran A, Brindha P, Mullaicharam A, Masilamani K. Liposomal Drug Delivery Systems – A Int J Pharm Sci Rev Res. 2013 Oct 31;1(23):295–301.
  15. Thap18a Magar K, Boafo GF, Li X, Chen Z, He W. Liposome- based delivery of biological drugs. Chin Chem Lett. 2022 Feb;33(2):587–96.
  16. Vijay Kumar, Kapil Kumar, Ikram, Aparna Joshi, Deepak A comprehensive review on liposomes: A vesicular system for drug delivery. GSC Biol and Pharm Sci. 2022 Feb 28;18(2):331–7.
  17. Shashi K, Satinder K, Bharat P. A COMPLETE REVIEW ON: liposomes. Int. Res. J. Pharm. 2012;3(7):10–6.
  18. Elsana H, Olusanya TO, Carr-Wilkinson J, Darby S, Faheem A, Elkordy AA. Evaluation of novel cationic gene based liposomes with cyclodextrin prepared by thin film hydration and microfluidic systems. Scientific reports. 2019 Oct 22;9(1):15120.
  19. Danaei M, Dehghankhold M, Ataei S, Hasanzadeh Davarani F, Javanmard R, Dokhani A, Khorasani S, Mozafari MR. Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier Pharmaceutics. 2018 May 18;10(2):57.
  20. Kraft JC, Freeling JP, Wang Z, Ho RJ. Emerging research and clinical development trends of liposome and lipid nanoparticle drug delivery systems. J Pharm Sci. 2014 Jan 1;103(1):29-52.
  21. Kaszuba M, Corbett J, Watson FM, Jones High-concentration zeta potential measurements using light-scattering techniques. Philosophical transactions of the royal society a: mathematical, physical and engineering sciences. 2010 Sep 28;368(1927):4439- 51.
  22. Pattni BS, Chupin VV, Torchilin VP. New developments in liposomal drug Chem. Rev. 2015 Oct 14;115(19):10938- 66.
  23. Elizondo E, Moreno E, Cabrera I, Córdoba A, Sala S, Veciana J, Ventosa Liposomes and other vesicular systems: structural characteristics, methods of preparation, and use in nanomedicine. Prog Mol Biol Transl Sci. 2011 Jan 1;104:1-52.
  24. Nkanga CI, Bapolisi AM, Okafor NI, Krause General perception of liposomes: formation, manufacturing and applications. Liposomes-advances and perspectives. 2019 Mar 26.
  25. Zucker D, Marcus D, Barenholz Y, Goldblum A. Liposome drugs’ loading efficiency: a working model based on loading conditions and drug’s physicochemical properties. J Control Release 2009 Oct 1;139(1):73-80.
  26. Bakonyi M, Berkó S, Budai-Szűcs M, Kovács A, Csányi DSC for evaluating the encapsulation efficiency of lidocaine-loaded liposomes compared to the ultracentrifugation method. J. Therm. Anal. Calorim. 2017 Dec; 130:1619-25.
  27. Dash S, Murthy PN, Nath L, Chowdhury P. Kinetic modeling on drug release from controlled drug delivery Acta Pol Pharm. 2010 May 1;67(3):217-23.
  28. Šturm L, Poklar Ulrih Basic methods for preparation of liposomes and studying their interactions with different compounds, with the emphasis on polyphenols. Int. J. Mol. Sci. 2021 Jun 18;22(12):6547.
  29. Bangham AD, Hill MW, Miller NG. Preparation and use of liposomes as models of biological membranes. In Methods in membrane biology: Volume 1 1974 (pp. 1-68). Boston, MA: Springer US.
  30. Peng T, Xu W, Li Q, Ding Y, Huang Pharmaceutical liposomal delivery—specific considerations of innovation and challenges. Biomater. Sci. 2023;11(1):62-75.
  31. Gao Y, Liu X, Chen N, Yang X, Tang Recent Advance of Liposome Nanoparticles for Nucleic Acid Therapy. Pharmaceutics. 2023 Jan 4;15(1):178.
  32. Olga Popovska JS, Kavrakovski Z, Rafajlovska An Overview: Methods for Preparation and Characterization of Liposomes as Drug Delivery Systems Int. J. Pharm. Phytopharmacol. 2013;3(2):13-20.
  33. Kumar L, Verma S, Kumar S, Prasad DN, Jain AK. Fatty acid vesicles acting as expanding horizon for transdermal delivery. Artificial Cells, Nanomedicine, and Biotechnology. 2017 Feb 17;45(2):251–60.
  34. Sathe KP, Bangar Liposomes: an overview. World J. Pharm. Res. 2021 Feb 16;10(3):935–54.
  35. Akbarzadeh A, Rezaei-Sadabady R, Davaran S, Joo SW, Zarghami N, Hanifehpour Y, Samiei M, Kouhi M, Nejati-Koshki K. Liposome: classification, preparation, and Nanoscale Res. Lett. 2013 Dec; 8:1-9.
  36. Sherpa LS, Kumar I, Chaudhary A, Lepcha B. Liposomal drug delivery system: Method of preparations and applications. J. Pharm. Sci. Res. 2020 Sep 1;12(9):1192-7.
  37. Tayal S, Tiwari P, Sahu V, Sharma Role of Liposome as Novel Carrier Molecule. International Journal of Pharma Professional’s Research (IJPPR). 2023;14(3):141-50.
  38. Lombardo D, Kiselev MA. Methods of liposomes preparation: Formation and control factors of versatile nanocarriers for biomedical and nanomedicine Pharmaceutics. 2022 Feb 28;14(3):543.
  39. Dua JS, Rana AC, Bhandari AK. Liposome: methods of preparation and applications. Int J Pharm Stud Res. 2012 Apr;3(2):14-20.
  40. Minocha N, Kumar V. Nanostructure system: Liposome – A bioactive carrier in drug delivery systems. Materials Today: Proceedings. 2022 Oct;69(1):614–9.
  41. Joy R, George J, John Brief Outlook on Polymeric Nanoparticles, Micelles, Niosomes, Hydrogels and Liposomes: Preparative Methods and Action. Chemistry Select. 2022 Feb 11;7(6):1–18.
  42. Iqbal M, Zafar N, Fessi H, Elaissari Double emulsion solvent evaporation techniques used for drug encapsulation. Int. J. Pharm. 2015 Dec;496(2):173–90.
  43. Qian J, Guo Y, Xu Y, Wang X, Chen J, Wu X. Combination of micelles and liposomes as a promising drug delivery system: a review. Drug Deliv. Transl. Res. 2023 Jun 6:1-23.
  44. Amoabediny G, Haghiralsadat F, Naderinezhad S, Helder MN, Akhoundi Kharanaghi E, Mohammadnejad Arough J, Zandieh- Doulabi Overview of preparation methods of polymeric and lipid-based (niosome, solid lipid, liposome) nanoparticles: A comprehensive review. International Journal of Polymeric Materials and Polymeric Biomaterials. 2018 Apr 13;67(6):383- 400.
  45. Dhiman N, Sarvaiya J, Mohindroo P. A drift on liposomes to proliposomes: recent advances and promising approaches. J. Liposome Res. 2022 Oct 2;32(4):317–31.
  46. Chaudhury A, Das S, Lee RFS, Tan KB, Ng WK, Tan RBH, et al. Lyophilization of cholesterol-free PEGylated liposomes and its impact on drug loading by passive Int. J. Pharm. 2012 Jul;430(1–2):167–75.
  47. Trucillo P, Campardelli R, Reverchon E. Liposomes: From bangham to supercritical Processes. 2020 Aug 21;8(9):1022.
  48. Huang Z, Li X, Zhang T, Song Y, She Z, Li J, Deng Progress involving new techniques for liposome preparation. Asian J. Pharm. Sci. 2014 Aug 1;9(4):176-82.
  49. Vinita P, Shiv MK, Mahavir Y, Archana Liposome: a powerful approach festinates drug delivery system. Int J Drug Deliv Technol. 2013;3(1):7-10.
  50. Patil YP, Jadhav Novel methods for liposome preparation.Chem. Phys. Lipids 2014 Jan 1;177:8-18.
  51. Has C, Sunthar A comprehensive review on recent preparation techniques of liposomes. J. Liposome Res. 2020 Oct 1;30(4):336- 65.
  52. Guimarães D, Cavaco-Paulo A, Nogueira Design of liposomes as drug delivery system for therapeutic applications. Int. J. Pharm. 2021 May 15; 601:120571.
  53. Lehner R, Wang X, Marsch S, Hunziker Intelligent nanomaterials for medicine: carrier platforms and targeting strategies in the context of clinical application. Nanomedicine: Nanotechnology, Biology and Medicine. 2013 Aug 1;9(6):742-57.
  54. Wicki A, Witzigmann D, Balasubramanian V, Huwyler J. Nanomedicine in cancer therapy: challenges, opportunities, and clinical applications. Journal of controlled release. 2015 Feb 28;200:138-57.
  55. Noble GT, Stefanick JF, Ashley JD, Kiziltepe T, Bilgicer B. Ligand-targeted liposome design: challenges and fundamental Trends in biotechnology. 2014 Jan 1;32(1):32-45.
  56. Marqués-Gallego P, de Kroon Ligation strategies for targeting liposomal nanocarriers. BioMed research international. 2014 Jul 14;2014.
  57. Gogoi, , Kumar, N., Patra, S., 2016. Multifunctional Magnetic Liposomes for Cancer Imaging and Therapeutic Applications. Nanoarchitectonics for Smart Delivery and Drug Targeting. 2016; 743–782.
  58. Bozzuto G, Molinari A. Liposomes as nanomedical IntJ Nanomed. 2015 Feb 2:975-99.
  59. Zylberberg C, Matosevic S. Pharmaceutical liposomal drug delivery: a review of new delivery systems and a look at the regulatory Drug delivery. 2016 Nov 21;23(9):3319-29.
  60. Byrne JD, Betancourt T, Brannon-Peppas L. Active targeting schemes for nanoparticle systems in cancer therapeutics. Adv. Drug Deliv. Rev. 2008 Dec 14;60(15):1615-26.
  61. Chudasma MP, Shah SA, Qureshi MH, Shah N, Shah D, Trivedi R, Shah VH. Brief Insight on Nanovesicular Liposomes as Drug-delivery Carriers for Medical Applications. J. explor. res. pharmacol. 2023 Apr 27(000):0.
  62. Laouini A, Jaafar-Maalej C, Limayem-Blouza I, Sfar S, Charcosset C, Fessi H. Preparation, characterization and applications of liposomes: state of the art. J. Colloid Sci. Biotechnol. 2012 Dec 1;1(2):147-68.
  63. Gao Y, Huang H, Wang X, Bai B, Huang Y, Yang H, Zhang Q, Li Y, Li Y, Zhou M, Yang Safety and efficacy of mitoxantrone hydrochloride liposome in patients with relapsed or refractory peripheral T- cell lymphoma and extranodal NK/T- cell lymphoma: A prospective, single-arm, open-label, multi-center, phase II clinical trial. Blood. 2020 Nov 5;136:36-7.
  64. Safra T. Cardiac safety of liposomal anthracyclines. The oncologist. 2003 Aug 1;8(S2):17-24.
  65. Fulton MD, Najahi-Missaoui Liposomes in Cancer Therapy: How Did We Start and Where Are We Now. Int. J. Mol. Sci. 2023 Apr 1;24(7):6615
  66. Barenholz YC. Doxil®—The first FDA-approved nano-drug: Lessons learned. J. Control. Release. 2012 Jun 10;160(2):117-34.
  67. Lyon PC, Griffiths LF, Lee J, Chung D, Carlisle R, Wu F, Middleton MR, Gleeson FV, Coussios Clinical trial protocol for TARDOX: a phase I study to investigate the feasibility of targeted release of lyso-thermosensitive liposomal doxorubicin (ThermoDox®) using focused ultrasound in patients with liver tumours. Journal of therapeutic ultrasound. 2017 Dec;5(1):1-8.
  68. Patel R, Patel H, Baria A. Formulation and evaluation of liposomes of ketoconazole. International Journal of Drug Delivery Technology. 2009 Aug 21;1(1).
  69. Jehn, F.; Boulikas, T.; Kourvetaris, A.; Possinger, K.; Lüftner, D. Pharmacokinetics of liposomal cisplatin (lipoplatin) in combination with 5-FU in patients with advanced head and neck cancer: First results of a phase III study. Anticancer Res. 2007, 27, 471–475.
  70. Luiz H, Oliveira Pinho J, Gaspar Advancing Medicine with Lipid-Based Nanosystems—The Successful Case of Liposomes. Biomedicines. 2023 Feb 2;11(2):435.
  71. Mifamurtide: CGP 19835, CGP 19835A, L-MTP-PE, liposomal MTP-PE, MLV 19835A, MTP-PE, muramyltripeptide Drugs R D 2008, 9, 131–135.
  72. Karaz S, Senses E. Liposomes Under Shear: Structure, Dynamics, and Drug Delivery Applications. Advanced Nano Biomed Research. 2023:2200101
  73. Wang S, Chen Y, Guo J, Huang Liposomes for tumor targeted therapy: A review. Int. J. Mol. Sci. 2023 Jan 31;24(3):2643.
  74. Fulton MD, Najahi-Missaoui Liposomes in Cancer Therapy: How Did We Start and Where Are We Now. Int. J. Mol. Sci. 2023 Apr 1;24(7):6615.
  75. Grygorieva G, Pylypenko D, Krasnopolsky Liposomes: from August Wassermann to Vaccines Against COVID-19. ADMET and DMPK. 2023 Jun 30
  76. Saraf S, Jain A, Tiwari A, Verma A, Panda PK, Jain Advances in liposomal drug delivery to cancer: An overview. J Drug Deliv Sci Technol. 2020 Apr 1; 56:101549.
  77. Vartak R, Patil SM, Saraswat A, Patki M, Kunda NK, Patel K. Aerosolized nanoliposomal carrier of remdesivir: an effective alternative for COVID-19 treatment in Nanomedicine.2021 Mar;16(14):1187-202.
  78. Nisini R, Poerio N, Mariotti S, De Santis F, Fraziano M. The multirole of liposomes in therapy and prevention of infectious diseases. Front. Immunol. 2018 Feb 5; 9:155.
  79. Matos CM. Liposomes: The Brave Old World. International Journal of Molecular Sciences. 2023 Feb 22;24(5):4343.
  80. Ng ZY, Wong JY, Panneerselvam J, Madheswaran T, Kumar P, Pillay V, Hsu A, Hansbro N, Bebawy M, Wark P, Hansbro Assessing the potential of liposomes loaded with curcumin as a therapeutic intervention in asthma. Colloids and surfaces B: Biointerfaces. 2018 Dec 1; 172:51-9.
  81. Allahou LW, Madani SY, Seifalian A. Investigating the application of liposomes as drug delivery systems for the diagnosis and treatment of cancer. Int. J. Biomater. 2021 Sep 1;2021.
  82. Fukuta T, Oku N, Kogure Application and Utility of Liposomal Neuroprotective Agents and Biomimetic Nanoparticles for the Treatment of Ischemic Stroke. Pharmaceutics. 2022 Feb 4;14(2):361.
  83. Bhattacharya S, Saindane D, Prajapati BG. Liposomal Drug Delivery and Its Potential Impact on Cancer ACAMC. 2022 Sep;22(15):2671–83.
  84. Moradi M, Vahedi F, Abbassioun A, Ramezanpour Shahi A, Sholeh M, Taheri‐Anganeh M, Dargahi Z, Ghanavati R, Khatami SH, Movahedpour A. Liposomal delivery system/adjuvant for tuberculosis vaccine. Immunity, Inflammation and Disease. 2023 Jun;11(6):e867.
  85. Olusanya TO, Haj Ahmad RR, Ibegbu DM, Smith JR, Elkordy Liposomal drug delivery systems and anticancer drugs. Molecules. 2018 Apr 14;23(4):907.
  86. Duong VA, Nguyen TT, Maeng Recent advances in intranasal liposomes for drug, gene, and vaccine delivery. Pharmaceutics. 2023 Jan 6;15(1):207.
  87. Luiz MT, Dutra JAP, Tofani LB, De Araújo JTC, Di Filippo LD, Marchetti JM, et al. Targeted Liposomes: A Nonviral Gene Delivery System for Cancer Therapy. Pharmaceutics. 2022 Apr 8;14(4):821.
  88. Morand K, Bartoletti AC, Bochot A, Barratt G, Brandely ML, Chast F. Liposomal amphotericin B eye drops to treat fungal keratitis: physico-chemical and formulation stability. Int. J. Pharm. 2007 Nov 1;344(1-2):150-3.
  89. Craig JP, Purslow C, Murphy PJ, et al. Effect of a liposomal spray on the pre-ocular tear Cont Lens Anterior Eye. 2010; 33:83–87
  90. Taha EI, El-Anazi MH, El-Bagory IM, et al. Design of liposomal colloidal systems for ocular delivery of ciprofloxacin. Saudi Pharm J. 2014; 22:231–239.
  91. Huang Y, Tao Q, Hou D, et al. A novel ion-exchange carrier based upon liposome-encapsulated montmorillonite for ophthalmic delivery of betaxolol hydrochloride. Int J Nanomed. 2017; 12:1731–1745.
  92. Nambiar NR, Gaur S, Ramachandran G, Pandey RS, Nath LR, Dutta T, Sudheesh Remote loading in liposome: a review of current strategies and recent developments. Journal of Liposome Research. 2024 Feb 10;1-3.
  93. Gupta A, Mandal M, Singh B, Yashwant Y, Jhanwar B. Liposomes: Current Approaches for Development and Evaluation. International Journal of Drug Delivery 2017 Dec 7; 4.
  94. Nsairat H, Ibrahim AA, Jaber AM, Abdelghany S, Atwan R, Shalan N, Abdelnabi H, Odeh F, El-Tanani M, Alshaer W. Liposome bilayer stability: Emphasis on cholesterol and its Journal of Liposome Research. 2024 Jan 2;34(1):178-202.
  95. Sahoo CK, Sahoo NK, Sahu Liposomes for the treatment of prostate cancer therapy: A review. Cancer Treatment and Research Communications. 2024 Feb 1:100792.